Founded by research scientists and entrepreneurs in 2002, GenomeScan is a privately-owned company based in Leiden, The Netherlands. GenomeScan is a leading and innovative company in the field of genetic analyses. The company’s mission is to partner with hospitals, academic institutions, and global pharmaceutical and biotechnology companies to accelerate disease diagnostics and prediction, support clinician decision making, and improve the quality of life for patients suffering from genetic disorders.
GenomeScan truly understands customers’ needs and develops tailored solutions. The company combines in-house expertise with a close collaboration with clinical experts from the prestigious Erasmus Medical Center and Leiden University Medical Center to develop an in-depth knowledge and understanding of a wide range of research methodologies and data-analysis and -interpretation relevant to clinical practice.
In addition to providing patient stratification strategies based on NGS genetic profiling to pharmaceutical companies, GenomeScan’s services portfolio encompasses the latest sequencing technologies including whole exome sequencing, panel sequencing, transcriptomics, and epigenetics.
GenomeScan maintains an accredited DNA testing facility (ISO/IEC 17025 accredited for NGS, also offering GCLP and GLP compliance for a variety of tests for large clinical and preclinical studies). The in-house laboratory is fully equipped to perform genetic tests for large clinical and drug development studies and deliver genetic profiles or diagnostics (including data interpretation) in 48 hours. Our industry-scale sequencers (NovaSeq 6000, PacBio Sequel), robotics and IT infrastructure have ample capacity to accommodate both research and diagnostics projects. An experienced bioinformatics team has developed pipelines for all our current services that can be customized to generate a comprehensive report tailored to your needs.
|
|
|
|
|
51-200 employees
View all GenomeScan employees
|
|
|
Biotechnology Research
|
|
|
$1M–$5M
|
|
|
+31 20 123 4567
|
|
|
Plesmanlaan, 1d, Leiden, South Holland 2333 ZA, NL
|
|
|
2002
|
|
|
Project Management, Experienced Team, Next Generation Sequencing, Whole Genome Sequencing, Accredited Laboratory, Ngs Genetic Testing And Diagnostics, Reliable High Quality Data, Research & Development On Genetic Testing, Targeted Disease Panels, Disease Panels, Whole Exom Sequencing
|
Kees Van Den Berg is the CEO of GenomeScan. To contact Kees Van Den Berg email at [email protected].
GenomeScan headquarters is located at Plesmanlaan, 1d, Leiden, South Holland 2333 ZA, NL.
GenomeScan generates an estimated $5M–$20M annually, based on industry analysis and publicly available market data.
You can contact GenomeScan by calling +31 20 123 4567.
GenomeScan headquarters is located at Plesmanlaan, 1d, Leiden, South Holland 2333 ZA, NL.
GenomeScan generates an estimated $1M–$5M annually, based on industry analysis and publicly available market data.
You can contact GenomeScan by calling +31 20 123 4567.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.